F270-0569 Screening compound: 6-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

F270-0569 Screening compound: 6-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one
F270-0569 Screening compound: 6-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F270-0569
6-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F270-0569

Molecular Formula

C16H20N4O5 (C16 H20 N4 O5)

Compound Name

6-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

IUPAC name

6-(2-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-34-dimethyl-6H7H-[12]oxazolo[34-d]pyridazin-7-one

SMILES

Cc(onc12)c2C(C)=NN(CC(N(CC2)CCC22OCCO2)=O)C1=O

InChI

InChI=1S/C16H20N4O5/c1-10-13-11(2)25-18-14(13)15(22)20(17-10)9-12(21)19-5-3-16(4-6-19)23-7-8-24-16/h3-9H2,1-2H3

InChI Key

IIWXGJHRVALVPW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111177

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

348.36

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

-0.496

Distribution Coefficient, logD

-0.496

Water Solubility, LogSw

0.17

Polar Surface Area

79.792

Acid Dissociation Constant (pKa)

18.22

Base Dissociation Constant (pKb)

0.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

62.50

F270-0569 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Others
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F270-0569 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F270-0569?
Check Price and Availability of F270-0569, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F270-0569 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F270-0569
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F270-0569
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F270-0569 available by request